These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15309245)

  • 21. Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.
    Kom GD; Schwedhelm E; Maas R; Schneider L; Benndorf R; Böger RH
    Br J Clin Pharmacol; 2007 Jun; 63(6):672-9. PubMed ID: 17214829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
    Fan P; Liu H; Wang Y; Zhang F; Bai H
    Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetes.
    Winkler K; Abletshauser C; Friedrich I; Hoffmann MM; Wieland H; März W
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1153-9. PubMed ID: 15001601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
    Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
    Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
    Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients.
    Phumala Morales N; Cherlermchoung C; Fucharoen S; Chantharaksri U
    Clin Chem Lab Med; 2007; 45(7):884-9. PubMed ID: 17617032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
    Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity and distribution of plasma platelet-activating factor acetylhydrolase in women with gestational diabetes mellitus and their neonates.
    Gao Q; He GL; Zhang L; Bai H; Liu XH; Fan P
    Diabetes Metab Res Rev; 2016 Sep; 32(6):634-42. PubMed ID: 26789131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum platelet-activating factor acetylhydrolase activity: a novel potential inflammatory marker in type 1 diabetes.
    Gomes MB; Cobas RA; Nunes E; Nery M; Castro-Faria-Neto HC; Tibiriçá E
    Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):42-6. PubMed ID: 18718550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
    Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
    Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of estrogen and progesterone on platelet-activating factor acetylhydrolase activity in ovariectomised rats.
    Ohshige A; Ito M; Koyama H; Maeda T; Yoshimura T; Okamura H
    Artery; 1994; 21(4):234-42. PubMed ID: 8830649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity.
    Tselepis AD; Elisaf M; Besis S; Karabina SA; Chapman MJ; Siamopoulou A
    Arthritis Rheum; 1999 Feb; 42(2):373-83. PubMed ID: 10025933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
    Wójcicka G; Zaręba M; Warpas A; Jamroz-Wiśniewska A; Rusek M; Czechowska G; Bełtowski J
    Eur J Pharmacol; 2019 May; 850():180-189. PubMed ID: 30768981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL.
    Tselepis AD; Karabina SA; Stengel D; Piédagnel R; Chapman MJ; Ninio E
    J Lipid Res; 2001 Oct; 42(10):1645-54. PubMed ID: 11590221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals.
    Campo S; Sardo MA; Bitto A; Bonaiuto A; Trimarchi G; Bonaiuto M; Castaldo M; Saitta C; Cristadoro S; Saitta A
    Clin Chem; 2004 Nov; 50(11):2077-82. PubMed ID: 15364890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bovine platelet-activating factor acetylhydrolase (PAF-AH) activity related to fertility.
    Turk R; Juretić D; Geres D; Bacić G; Milesević M; Flegar-Mestrić Z; Turk N; Svetina A
    Anim Reprod Sci; 2008 May; 105(3-4):344-53. PubMed ID: 17442508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.